搜索筛选:
搜索耗时5.6331秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
类      型:
[期刊论文] 作者:Shanqi Guo,Xingkang Jiang,Xiao, 来源:TMR临床研究 年份:2019
DNA修复基因在维持基因组稳定性和完整性方面具有重要作用。已有报道显示着色性干皮病D组基因(XPD)的多态性与前列腺癌(PCa)相关,但结论仍有争议。本研究的目的是对两种常见...
[会议论文] 作者:Shanqi Guo,Linlin Zhao,Xiaojiang Li,Yingjie Jia, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:bing xia,chen tian,shanqi guo,le zhang,fulian qu,yizhuo zhang, 来源:The 35th World Congress of the International Society of Hema 年份:2014
Acute myeloid leukemia (AML) is a malignant disease not sensitive to chemotherapy.The dynamic interaction between AML cells and bone marrow (BM) microenvironment plays a critical role in response of t...
[会议论文] 作者:Bing Xia,Fulian Qu,Xiaowu Li,Shanqi Guo,Fang Li,Xin Jin,Chen Tian,Yong Yu,Yafei Wang,Yizhuo Zhang, 来源:中国老年学和老年医学学会老年肿瘤分会年会暨第十届中国老年肿瘤学大会 年份:2016
Ibrutinib,an irreversible Brutons tyrosine kinase inhibitor,induces significant clinical responses in B-cell malignancies.Our study aimed to elucidate ibrutinibs actions on diffuse large B-cell lympho...
[会议论文] 作者:Bing Xia,Fulian Qu,Xiaowu Li,Shanqi Guo,Fang Li,Xin Jin,Chen Tian,Yong Yu,Yafei Wang,Wanming Da,Liang, 来源:第十五届全国实验血液学学术会议 年份:2015
Ibrutinib, an irreversible Brutons tyrosine kinase (BTK) inhibitor, has induced significant clinical responses in B-cell malignancies.Our study is to elucidate its actions on diffuse large B-cell lymp...
相关搜索: